Russia expects to register a possible second vaccine to prevent COVID-19 by October 15.

The vaccine was developed by the Victor Institute in Siberia, which completed early human trials of it last week.

Russia registered its first candidate vaccine against Corona, which was developed by the Aesthetic Institute in Moscow in August, and the last-phase trials, involving at least 40,000 people, are still ongoing.